Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).
Bruyere O, Kanis JA, Ibar-Abadie ME, Alsayed N, Brandi ML, Burlet N, Cahall DL, Chines A, Devogelaer JP, Dere W, Goel N, Hughes N, Kaufman JM, Korte S, Mitlak BH, Niese D, Rizzoli R, Rovati LC, Reginster JY. Bruyere O, et al. Among authors: mitlak bh. Osteoporos Int. 2010 May;21(5):713-22. doi: 10.1007/s00198-010-1190-9. Epub 2010 Mar 18. Osteoporos Int. 2010. PMID: 20238101
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.
Compston J, Reid DM, Boisdron J, Brandi ML, Burlet N, Cahall D, Delmas PD, Dere W, Devogelaer JP, Fitzpatrick LA, Flamion B, Goel N, Korte S, Laslop A, Mitlak B, Ormarsdottir S, Ringe J, Rizzoli R, Tsouderos Y, Van Staa T, Reginster JY; Group for the Respect of Ethics and Excellence in Science. Compston J, et al. Osteoporos Int. 2008 Sep;19(9):1247-50. doi: 10.1007/s00198-008-0670-7. Epub 2008 Jul 5. Osteoporos Int. 2008. PMID: 18604578 No abstract available.
Adherence to treatment of osteoporosis: a need for study.
Lekkerkerker F, Kanis JA, Alsayed N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kaufman JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY; Group for the Respect of Ethics and Excellence in Science (GREES). Lekkerkerker F, et al. Osteoporos Int. 2007 Oct;18(10):1311-7. doi: 10.1007/s00198-007-0410-4. Epub 2007 Jun 22. Osteoporos Int. 2007. PMID: 17585359 Free article. Review.
Frailty and sarcopenia: definitions and outcome parameters.
Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, Sieber CC, Kaufman JM, Abellan van Kan G, Boonen S, Adachi J, Mitlak B, Tsouderos Y, Rolland Y, Reginster JY. Cooper C, et al. Osteoporos Int. 2012 Jul;23(7):1839-48. doi: 10.1007/s00198-012-1913-1. Osteoporos Int. 2012. PMID: 22290243 Review.
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men.
Reginster JY, Abadie E, Delmas P, Rizzoli R, Dere W, der Auwera P, Avouac B, Brandi ML, Daifotis A, Diez-Perez A, Calvo G, Johnell O, Kaufman JM, Kreutz G, Laslop A, Lekkerkerker F, Mitlak B, Nilsson P, Orloff J, Smillie M, Taylor A, Tsouderos Y, Ethgen D, Flamion B. Reginster JY, et al. Osteoporos Int. 2006 Jan;17(1):1-7. doi: 10.1007/s00198-005-1984-3. Epub 2005 Aug 10. Osteoporos Int. 2006. PMID: 16091835
Treatment of osteoporosis in men.
Kaufman JM, Reginster JY, Boonen S, Brandi ML, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, McCloskey E, Mitlak B, Orwoll E, Ringe JD, Weryha G, Rizzoli R. Kaufman JM, et al. Bone. 2013 Mar;53(1):134-44. doi: 10.1016/j.bone.2012.11.018. Epub 2012 Nov 28. Bone. 2013. PMID: 23201268 Free PMC article. Review.
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia.
Reginster JY, Cooper C, Rizzoli R, Kanis JA, Appelboom G, Bautmans I, Bischoff-Ferrari HA, Boers M, Brandi ML, Bruyère O, Cherubini A, Flamion B, Fielding RA, Gasparik AI, Van Loon L, McCloskey E, Mitlak BH, Pilotto A, Reiter-Niesert S, Rolland Y, Tsouderos Y, Visser M, Cruz-Jentoft AJ. Reginster JY, et al. Among authors: mitlak bh. Aging Clin Exp Res. 2016 Feb;28(1):47-58. doi: 10.1007/s40520-015-0517-y. Epub 2015 Dec 30. Aging Clin Exp Res. 2016. PMID: 26717937 Free PMC article. Review.
FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.
Harvey NC, Kanis JA, Odén A, Burge RT, Mitlak BH, Johansson H, McCloskey EV. Harvey NC, et al. Among authors: mitlak bh. Osteoporos Int. 2015 Nov;26(11):2677-84. doi: 10.1007/s00198-015-3173-3. Epub 2015 Jun 20. Osteoporos Int. 2015. PMID: 26092063 Free PMC article. Clinical Trial.
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.
Abadie EC, Devogealer JP, Ringe JD, Ethgen DJ, Bouvenot GM, Kreutz G, Laslop A, Orloff JJ, Vanderauwera PM, Delmas PD, Dere WH, Branco J, Altman RD, Avouac BP, Menkes CJ, Vanhaelst L, Mitlak BH, Tsouderos Y, Reginster JY. Abadie EC, et al. Among authors: mitlak bh. Semin Arthritis Rheum. 2005 Aug;35(1):1-4. doi: 10.1016/j.semarthrit.2005.03.006. Semin Arthritis Rheum. 2005. PMID: 16084217 Review.
92 results